Combination Flu-Covid19 Vaccine Clinical Trial For Seniors
(Combo) Flu-Covid19 Vaccination for Seniors Study
Pursuing Protection From the Flu & COVID-19
One shot for Flu and COVID-19!
Together, let’s make vaccination easier.
About the Combo Flu-Covid19 Vaccine Study
The FLU SV–SARS-COV2 COMBO-010 clinical trial study is evaluating a new investigational vaccine. This vaccine is designed to protect against both the Seasonal Flu and COVID-19.
You may be able to take part in the Combo Flu/Covid-19 Vaccine Study if you:
- Are aged 65-85
- Are healthy, or have a stable medical condition. This means your condition has not required significant changes to your treatment or a hospital stay for worsening symptoms in the past three months
- Are able to follow the study instructions, use the electronic diary (eDiary) with or without assistance of a caregiver, and return for follow up visits
- Are not overweight (Have a BMI between 18kg/m2 and 33kg/m2, inclusive)
You may receive compensation up to $1,100 for inconvenience and travel.
If you are interested in participating, the study doctor and staff will review additional eligibility criteria with you and answer any questions you may have.


By taking part in this study, you can help assess this combined vaccine, which may simplify your annual vaccination.
Call (561) 689-0606 or
Complete The Questionnaire Below To Apply
This study focuses on seasonal influenza (the flu) and COVID-19, which are both respiratory illnesses.
The flu is a seasonal virus, while COVID-19 can occur year-round. Both flu and COVID-19 viruses change overtime and that’s why vaccines for both are updated yearly to offer protection.
This study is being done to test a new combined vaccine designed to protect against both illnesses. It aims to find out if the study vaccine is safe and how well a participant’s body responds to it. This research helps us learn more about its effects.

Call (561) 689-0606 or
Complete The Questionnaire Below To Apply

Diversity in Clinical Research Studies
People may experience weight loss differently based on their race, ethnicity, gender, age, and background. That’s why our Flu-Covid19 Combo Vaccine Study for Seniors is committed to including a diverse range of participants. We aim to ensure that people from various communities are represented, helping us understand how the investigational medication works across different groups. By prioritizing diversity, we can gain a more complete picture of its effectiveness, ultimately leading to better treatment options for everyone. Your unique experience matters in making a difference!
Why are clinical studies important?
Clinical trials are the best way to find out if new treatments or vaccines work and how safe they are. If clinical trials show that a new treatment works and is safe, then it can be approved to be used by the people who need it.
Not all clinical trials test a new treatment or vaccine. “Observational” studies collect information about people’s health during their normal care. This helps researchers learn more about specific health issues.

What is a clinical research study?
A clinical research study is a medical study that helps to answer important questions about an investigational medication or vaccine. such as:
- Is it effective?
- What amount. or dose. may work best?
- How safe is it?
- Are there side effects?
All medications and vaccines must be tested in clinical research studies before they can be approved for use. Without people taking part in these studies, we would have no new medications or vaccines
Clinical research studies should include groups of people who may be at higher risk based on their age, sex. and race/ethnicity.
An Institutional Review Board (IRB)/Ethics Committee (EC), which protects the rights, safety, and wellbeing of the participants has approved this study.

